SCHEMBL6678724

SCHEMBL6678724

C[C@H]1O[C@@H](n2cc(I)c3c(Nc4ccc(Cl)cc4)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.83

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 20/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8975073 0.90 ADK (1.00) ADK
SCHEMBL8469616 0.85 ADK (1.00) ADK
SCHEMBL8332154 0.83 ADK (1.00) ADK
SCHEMBL8320660 0.83 ADK (1.00) ADK
SCHEMBL8330319 0.81 ADK (1.00) ADK
SCHEMBL6678245 0.81 ADK (1.00) ADK
SCHEMBL8328787 0.78 ADK (0.79) ADK
SCHEMBL8975148 0.77 ADK (1.00) ADK
SCHEMBL8321626 0.77 ADK (0.76) ADK
SCHEMBL8324099 0.77 ADK (0.83) ADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832092-B1 ORALLY ACTIVE ADENOSINE KINASE INHIBITORS METABASIS THERAPEUTICS INC (US) 2004-11-17 — — EP disclosed
Send feedback